Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Sampling from Storage Tank – V 2.0

Posted on By

Elixir Department: SOP for Sampling from Storage Tank – V 2.0

Standard Operating Procedure for Sampling from Storage Tank in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/081/2025
Supersedes SOP/ELX/081/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for collecting representative samples from the storage tank containing bulk elixir solution for the purpose of quality control testing, ensuring uniformity, compliance, and traceability.

2. Scope

This SOP applies to the collection of in-process, final bulk, and stability samples from storage tanks in the Elixir Department before filtration or filling.

3. Responsibilities

  • Production Operator:
    • Clean sampling point, perform sample withdrawal, and label samples correctly.
  • QC Chemist:
    • Receive samples, perform testing, and record results.
  • QA Officer:
    • Verify sample label details and ensure documentation is accurate and complete.
See also  Elixir Department: SOP for Verification of Final Product Volume - V 2.0

4. Accountability

The Head of Production is accountable for ensuring samples are taken in a GMP-compliant manner and reflect true batch quality.

5. Procedure

5.1 Pre-Sampling Preparation

  1. Verify that the storage tank is labeled with product name, batch number, and volume.
  2. Confirm that
the sampling point is accessible, sanitized, and within expiry of cleaning validation.
  • Assemble sterile sampling containers, labels, gloves, and a sanitized tray.
  • 5.2 Sampling Technique

    1. Wipe the sampling valve and adjacent area with sterile lint-free cloth soaked in 70% IPA.
    2. Open the valve and discard a small initial quantity (approx. 50 mL) to flush the line.
    3. Collect samples as per requirement:
      • For QC testing: 3 containers (Top, Middle, Bottom)
      • For stability or retain: 1 container (composite sample)
    4. Close the sampling valve securely after collection.

    5.3 Labeling and Dispatch

    1. Label each sample container with:
      • Product Name
      • Batch Number
      • Sample Type (Top/Middle/Bottom/Composite)
      • Sampling Date and Time
      • Sampled By
    2. Send samples to the QC laboratory along with the Sample Intimation Slip (Annexure-1).

    5.4 Documentation

    1. Record sampling activity in the Sampling Logbook (Annexure-2).
    2. Attach a copy of the log to the BMR and retain original with QA.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • IPA: Isopropyl Alcohol

    7. Documents

    1. Sample Intimation Slip (Annexure-1)
    2. Sampling Logbook (Annexure-2)
    3. Batch Manufacturing Record (BMR)

    8. References

    • 21 CFR Part 211.110 – Sampling and Testing of In-Process Materials
    • WHO TRS 1010 – GMP for Pharmaceutical Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Sample Intimation Slip

    Product Name Batch No. Sample Type Quantity Sampling Date Sampled By
    Paracetamol Elixir ELX-1020 Composite 100 mL 11/04/2025 Rajesh Kumar

    Annexure-2: Sampling Logbook

    Date Batch No. Sample Type Volume Time Operator Remarks
    11/04/2025 ELX-1020 Top/Middle/Bottom 3 x 100 mL 11:00 AM Rajesh Kumar Clean sampling observed

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Added Sampling Types and Intimation Slip QA Recommendation QA Head
    See also  Elixir Department: SOP for Microbial Sampling During Process - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: Linearity Study Using UV – V 2.0
    Next Post: Biosimilars: SOP for Primary Clarification Using Depth Filters in Bioreactor Operations – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version